Antenatal Corticosteroids in the Management of Preterm Birth: Are We Back Where We Started?

Obstetrics and Gynecology Clinics of North America

Volumn 39, Issue 1, 2012, Pages 47-63

  Bonanno, Clarissa ^a   Wapner, Ronald J ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Corticosteroids; Neonatal mortality; Prematurity; Preterm birth; Respiratory distress

Indexed keywords

BETAMETHASONE; BETAMETHASONE ACETATE PLUS BETAMETHASONE SODIUM PHOSPHATE; CORTICOSTEROID; DEXAMETHASONE; HYDROCORTISONE; PLACEBO;

BRAIN HEMORRHAGE; CHORIOAMNIONITIS; DEVELOPMENTAL DISORDER; DRUG EFFICACY; DRUG SAFETY; FETUS MATURITY; HUMAN; INTRAUTERINE GROWTH RETARDATION; MEDICAL SOCIETY; MULTIPLE PREGNANCY; NECROTIZING ENTEROCOLITIS; NEWBORN MORBIDITY; NEWBORN MORTALITY; NONHUMAN; OBESITY; PRACTICE GUIDELINE; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIMARY PREVENTION; PRIORITY JOURNAL; RESPIRATORY DISTRESS; REVIEW; SEPSIS;

ADRENAL CORTEX HORMONES; BETAMETHASONE; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EVIDENCE-BASED MEDICINE; FEMALE; FETAL GROWTH RETARDATION; FETAL MEMBRANES, PREMATURE RUPTURE; HUMANS; INFANT MORTALITY; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREMATURE BIRTH; PRENATAL CARE; PRIMARY PREVENTION; UNITED STATES;

EID: 84857386410     PISSN: 08898545     EISSN: 15580474     Source Type: Journal    
DOI: 10.1016/j.ogc.2011.12.006     Document Type: Review

References (66)

1. Martin J.A., Hamilton B.E., Sutton P.D. Births: final data for 2006. Natl Vit Stat Rep 2009, 57:1-104.
2. Hamilton B.E., Martin J.A., Ventura S.J. Births: preliminary data for 2009. Natl Vit Stat Rep 2010, 59:1-19.
3. Martin J.A., Osterman M.J.K., Sutton P.D. Are preterm births on the decline in the United States?. Recent data from the National Vital Statistics System. NCHS Data Brief 2010, 39:1-8.
4. Liggins G.C. Premature delivery of foetal lambs infused with glucocorticoids. J Endocrinol 1969, 45:515-523.
5. Liggins G.C., Howie R.N. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972, 50:515-525.
6. Villee C.A., Villee D.B., Zuckerman J. Respiratory distress syndrome 1973, Academic Press, New York.
7. Leviton L.C., Baker S., Hassol A., et al. An exploration of opinion and practice patterns affecting low use of antenatal corticosteroids. Am J Obstet Gynecol 1995, 173:312-316.
8. Bronstein J.M., Goldenberg R.L. Practice variation in the use of corticosteroids: a comparison of eight data sets. Am J Obstet Gynecol 1995, 173:296-298.
9. Crowley P., Chalmers I., Kierse M.J. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. BJOG 1990, 97:11-25.
10. NIH Consensus Development Panel on the effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 1995, 273:413-418.
11. Antenatal corticosteroid therapy for fetal maturation. Int J Gynaecol Obstet 1995, 48:340-342. ACOG Committee Opinion.
12. Leviton L.C., Goldenberg R.L., Baker C.S., et al. Methods to encourage the use of antenatal corticosteroid therapy for fetal maturation: a randomized controlled trial. JAMA 1999, 281:46-52.
13. Planer B.C., Ballard R.A., Ballard P.L., et al. Antenatal corticosteroid (ANCS) use in preterm labor in the USA. Pediatr Res 1996, 39:110A.
14. Antenatal corticosteroids revisited: repeat courses. Obstet Gynecol 2000, 98:144-150. NIH Consensus Development Panel.
15. Roberts D., Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006, 3. CD004454.
16. Martin J.A., Hamilton B.E., Sutton P.D., et al. Births: final data for 2008. Natl Vit Stat Rep 2010, 59:1-72.
17. Blickstein I., Shinwell E., Lusky A., et al. Plurality-dependent risk of respiratory distress syndrome among very-low-birthweight infants and antepartum corticosteroid treatment. Am J Obstet Gynecol 2005, 192:360-364.
18. Batista L., Winovitch K.C., Rumney P.J., et al. A case-control comparison of the effectiveness of betamethasone to prevent neonatal morbidity and mortality in preterm twin and singleton pregnancies. Am J Perinatol 2008, 25:449-453.
19. Choi S.J., Song S.E., Seo E.S., et al. The effect of single or multiple courses of antenatal corticosteroid therapy on neonatal respiratory distress syndrome in singleton versus twin pregnancies. Aust NZ Obstet Gynaecol 2009, 49:173-179.
20. Quist-Therson E.C., Myhr T.L., Ohlsson A. Antenatal steroids to prevent respiratory distress syndrome: multiple gestation as an effect modifier. Acta Obstet Gynecol Scand 1999, 78:388-392.
21. Ballabh P., Lo E.S., Kumari J., et al. Pharmacokinetics of betamethasone in twin and singleton pregnancy. Clin Pharmacol Ther 2002, 71:39-45.
22. Gyamfi C., Mele L., Wapner R.J., et al. The effect of plurality and obesity on betamethasone concentrations in women at risk for preterm delivery. Am J Obstet Gynecol 2010, 203:219.e1-219.e5.
23. Chescheir N.C. Global obesity and the effect on women's health. Obstet Gynecol 2011, 117:1213-1222.
24. Weiss J.L., Malone F.D., Emig D., et al. Obesity, obstetric complications and cesarean delivery rate-a population-based screening study. Am J Obstet Gynecol 2004, 190:1091-1097.
25. McDonald S.D., Han Z., Mulla S., et al. Overweight and obesity in mothers and risk of preterm birth and low birthweight infants: a systematic review and meta-analysis. BMJ 2010, 341:c3428.
26. Hashima J.N., Lai Y., Wapner R.J. The effect of body mass index on neonatal outcome in women receiving a single course of antenatal corticosteroids. Am J Obstet Gynecol 2010, 202:263.e1-263.e5.
27. Bernstein I.M., Horbar J.D., Badger G.J., et al. Morbidity and mortality among very-low-birthweight neonates with intrauterine growth restriction. Am J Obstet Gynecol 2000, 182:198-206.
28. Schaap A.H., Wolf H., Bruinse H.W., et al. Effects of antenatal corticosteroid administration on mortality and long-term morbidity in early, preterm, growth-restricted infants. Obstet Gynecol 2001, 97:954-960.
29. Torrance H.L., Derks J.B., Scherion S.A., et al. Is antenatal steroid treatment effective in preterm IUGR fetuses?. Acta Obstet Gynecol Scand 2009, 88:1068-1073.
30. Miller S.L., Chai M., Loose J., et al. The effects of maternal betamethasone administration on the growth-restricted fetus. Endocrinology 2007, 148:1288-1295.
31. Vidaeff A.C., Blackwell S.C. Potential risks and benefits of antenatal corticosteroid therapy prior to preterm birth in pregnancies complicated by fetal growth restriction. Obstet Gynecol Clin North Am 2011, 38:205-214.
32. Onland W., de Laat M.W., Mol B.W., et al. Effects of antenatal corticosteroids given prior to 26' weeks gestation: a systematic review of randomized controlled trials. Am J Perinatol 2011, 28:33-44.
33. Gonzales L.W., Ballard P.L., Ertsey R., et al. Glucocorticoids and thyroid hormones stimulate biochemical and morphological differentiation of human fetal lung in organ culture. J Clin Endocrinol Metab 1986, 62:678-691.
34. Costeloe K., Hennessy E., Gibson A.T., et al. The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability. Pediatrics 2000, 106:659-671.
35. Hayes E.J., Paul D.A., Stahl G.E., et al. Effect of antenatal corticosteroids on survival for neonates born at 23 weeks of gestation. Obstet Gynecol 2008, 111:921-926.
36. Mori R., Kusada S., Fujimura M., et al. Antenatal corticosteroids promote survival of extremely preterm infants born at 22 to 23 weeks gestation. J Pediatr 2011, 110:114.e1.
37. Tyson J.E., Parikh N.A., Langer J., et al. Intensive care for extreme prematurity-moving beyond gestational age. NEJM 2008, 358:1672-1681.
38. Costeloe K. EPICure: facts and figures: why preterm labor should be treated. BJOG 2006, 113(Suppl):10-12. EPICure study group.
39. Green Top Guideline No 7: Antenatal corticosteroids to reduce neonatal morbidity and mortality 2010, Royal College of Obstetricians, Royal College of Obstetricians, London.
40. Tita A.T.N., Landon M.B., Spong C.Y., et al. Timing of elective repeat cesarean at term and neonatal outcomes. N Engl J Med 2009, 360:111-120.
41. Hansen A.K., Wisborg K., Uldbjerg N., et al. Risk of respiratory morbidity in term infants delivered by elective cesarean section: cohort study. BMJ 2008, 336:85-87.
42. Stutchfield P., Whitaker R., Russell I. Antenatal betamethasone and incidence of neonatal respiratory distress after elective cesarean section: a pragmatic randomized trial. BMJ 2005, 331:662.
43. Smolders-de Haas H., Neuvel J., Schumand B., et al. Physical development and medical history of children who were treated antenatally with corticosteroids to prevent respiratory distress syndrome: a 10- to 12-year followup. Pediatrics 1990, 86:65-70.
44. Dessens A.B., Haas H., Kpooe J.G. Twenty-year follow-up of antenatal corticosteroid treatment. Pediatrics 2000, 105:e77.
45. Mwansa-Kambafwile J., Cousens S., Hansen T., et al. Antenatal steroids in preterm labor for the prevention of neonatal deaths due to complications of preterm birth. Int J Epidemiol 2010, 39(Suppl):i122-i133.
46. Wu Y.W., Colford J.M. Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. JAMA 2000, 284:1417-1424.
47. Lee M.J., Davies J., Guinn D., et al. Single versus weekly courses of antenatal corticosteroids in preterm premature rupture of membranes. Obstet Gynecol 2004, 103:274-281.
48. Antenatal corticosteroid therapy for fetal maturation. Committee Opinion No. 475. Obstet Gynecol 2011, 117:422-424. American College of Obstetricians and Gynecologists (ACOG).
49. Buttgereit F., Brand M.D., Burmester G.R. Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: a novel glucocorticoid hierarchy. Biochem Pharmacol 1999, 58:363-368.
50. Brownfoot F.C., Crowther C.A., Middleton P. Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk for preterm birth. Cochrane Database Syst Rev 2008, 4. CD006764.
51. Lee B.H., Stoll B.J., McDonald S.A., et al. Adverse neonatal outcomes associated with antenatal dexamethasone versus antenatal betamethasone. Pediatrics 2006, 117:1503-1510.
52. Elimian A., Garry D., Figueroa R., et al. Antenatal betamethasone compared with dexamethasone (betacode trial): a randomized controlled trial. Obstet Gynecol 2007, 110:26-30.
53. Vermillion S.T., Soper D.E., Newman R.B. Is betamethasone effective for longer than 7 days after treatment?. Obstet Gynecol 2001, 97:491-493.
54. Peaceman A.M., Bajaj K., Kumar P., et al. The interval between a single course of antenatal steroids and delivery and its association with neonatal outcomes. Am J Obstet Gynecol 2005, 193:1165-1169.
55. Ring A.M., Garland J.S., Stafiel B.R., et al. The effect of a prolonged time interval between antenatal corticosteroid administration and delivery on outcomes in preterm neonates: a cohort study. Am J Obstet Gynecol 2007, 196:457.e1-457.e6.
56. Gates S., Brocklehurst P. Decline in effectiveness of antenatal corticosteroids with time to real birth: real or artifact?. BMJ 2007, 335:77-79.
57. Mahony R., McKeating A., Murphy T., et al. Appropriate antenatal corticosteroid use in women at risk for preterm birth before 34 weeks of gestation. BJOG 2010, 117:963-967.
58. McLaughlin K.J., Crowther C.A., Vigneswaran P., et al. Who remains undelivered more than seven days after a single course of prenatal corticosteroids and gives birth at less than 34 weeks?. Aust NZ J Obstet Gynecol 2002, 42:353-357.
59. Guinn D.A., Atkinson M.W., Sillivan L., et al. Single versus weekly courses of antenatal corticosteroids for women at risk of preterm delivery: a randomized controlled trial. JAMA 2001, 286:1581-1587.
60. Wapner R.J., Sorokin Y., Thom E.A., et al. Single versus weekly courses of antenatal corticosteroids: evaluation of safety and efficacy. Am J Obstet Gynecol 2006, 195:633-642.
61. Crowther C.A., Haslam R.R., Hiller J.E., et al. Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomized controlled trial. Lancet 2006, 367:1913-1919.
62. Crowther C.A., McKinlay C.J.D., Middleton P., et al. Repeat doses of prenatal corticosteroids for women at risk for preterm birth for improving neonatal health outcomes. Cochrane Database Syst Rev 2011, 6. CD003935.
63. Vermillion S.T., Bland M.L., Soper D.E. Effectiveness of a rescue dose of antenatal betamethasone after an initial single course. Am J Obstet Gynecol 2001, 185:1086-1089.
64. Garite T.J., Kurtzman J., Maurel K., et al. Impact of a 'rescue course' of antenatal corticosteroids: a multicenter randomized, placebo-controlled trial. Am J Obstet Gynecol 2009, 200:e1-e9. 248.
65. Antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol 2011, 117:422-424. ACOG Committee Opinion.
66. Stutchfield P., Whitaker R., Russell I., et al. Antenatal betamethasone and incidence of neonatal respiratory distress after elective cesarean section: pragmatic randomized trial. BMJ 2005, 331:662.